Recent Updates
Recently added Catalysts
CLDX Positive Sentiment Score: 70/100

Celldex Therapeutics to Present at Upcoming Investor Conferences

Tuesday, March 4, 2025 1 min read
Key Takeaway: Celldex Therapeutics, Inc. (NASDAQ:CLDX) has announced its participation in two upcoming investor conferences: the TD Cowen 45th Annual Health Care Conference on March 4th and the Leerink Partners Global Healthcare Conference on March 11th. Management will engage in fireside chats at both events, and live webcasts of these presentations will be available on their website. This participation highlights Celldex's commitment to transparency and investor engagement in their clinical-stage biotechnology efforts.

Market Sentiment Analysis

POSITIVE FACTORS

  • Celldex Therapeutics is actively engaging with investors through upcoming conferences.
  • The company is showcasing their innovative approach in biotechnology.
  • Live webcasts will allow broader access to the presentations.
  • Celldex is focusing on developing transformative therapeutics for serious conditions.

Full Press Release Details

HAMPTON, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:
TD Cowen 45th Annual Health Care Conference on Tuesday, March 4th at 1:50 p.m. ET
Leerink Partners Global Healthcare Conference on Tuesday, March 11th at 1:00 p.m. ET
Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Senior Vice President, Corporate Affairs & Administration
scavanaugh@celldex.com
ptill@meruadvisors.com

Frequently Asked Questions

When will Celldex participate in the TD Cowen conference?

Celldex will participate in the TD Cowen 45th Annual Health Care Conference on March 4 at 1:50 p.m. ET.

Where can I watch the live webcasts of Celldex's presentations?

Live webcasts can be accessed on the 'Events & Presentations' page on Celldex's website.

How long will replays of the conferences be available?

Replays of the conference presentations will be available for 90 days after the events.

What does Celldex Therapeutics focus on?

Celldex Therapeutics specializes in developing antibody-based therapeutics for severe diseases.

Tags: CLDX Viatris Investor Conferences Healthcare Celldex Therapeutics investor conferences biotech healthcare
Last updated: Mar 4, 2025